Full Text View
Tabular View
No Study Results Posted
Related Studies
Renin-Angiotensin Aldosterone System and Fibrinolysis Interaction in Humans-Specific Aim 3
This study is ongoing, but not recruiting participants.
Study NCT00685945   Information provided by Vanderbilt University
First Received: May 27, 2008   Last Updated: April 14, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Obesity
More general conditions related to this trial
Body Weight
Nutrition Disorders
Overnutrition
Overweight
Signs and Symptoms
Interventions listed in this trial
Isosorbide
Sildenafil
Additional drug interventions recognized in this trial
Bradykinin
Isosorbide Dinitrate
Isosorbide-5-mononitrate
Phosphodiesterase Inhibitors
Tissue Plasminogen Activator
More general drug interventions related to this trial
Cardiovascular Agents
Diuretics
Diuretics, Osmotic
Enzyme Inhibitors
Fibrin Modulating Agents
Fibrinolytic Agents
Hematologic Agents
Molecular Mechanisms of Pharmacological Action
Natriuretic Agents
Nitric Oxide Donors
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
Vanderbilt University
National Institutes of Health (NIH)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services